VX19-814-101: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safetyof VX-814 in PiZZ Subjects

Project: Research project

Project Details

Description

VX19-814-101: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of VX-814 in PiZZ Subjects
StatusActive
Effective start/end date1/6/206/6/21

Funding

  • Vertex Pharmaceuticals Incorporated

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.